Clinical Trials Logo

Clinical Trial Summary

The main aim of this study was to evaluate the effectiveness of melatonin in prevention of radiation induced oral mucositis clinically and biochemically.


Clinical Trial Description

The study was designed as randomized, controlled, clinical trial. patients who were undergoing chemoradiation were divided into two groups: Group I: was given conventional treatment. Group II: was given melatonin therapy in combination with the conventional treatment.

All patients were clinically evaluated at the start the radiotherapy, three weeks and six weeks later for pain and oral mucositis severity. in addition, the total antioxidant capacity of the melatonin was evaluated at the start of the radiotherapy and six weeks later. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03833570
Study type Interventional
Source Alexandria University
Contact
Status Completed
Phase Phase 2
Start date January 12, 2018
Completion date December 1, 2018

See also
  Status Clinical Trial Phase
Recruiting NCT01318889 - Dexpanthenol Mouthwash to Treat Oral Mucositis Phase 2
Recruiting NCT06285591 - Lactobacillus Reuteri Alleviates Oral Mucositis in Patients Undergoing Radiotherapy for Malignant Head and Neck Tumors N/A
Completed NCT04699487 - Efficacy and Safety of CareMin650 for Prevention of Oral Mucositis in HNC Patients Starting Radiotherapy N/A
Not yet recruiting NCT05664906 - Evaluating Chinese Medicine Oral Rinse for Irradiated Oral Mucositis in Head & Neck Cancer Patients Phase 1/Phase 2
Active, not recruiting NCT03387774 - Efficacy of Ulinastatin for Reducing Radiation-Induced Oral Mucositis in Nasopharyngeal Carcinoma Patients Phase 3
Recruiting NCT05322421 - Effectiveness of Topical Olive Oil in Prevention and Management of Radiation Induced Oral Mucositis N/A
Active, not recruiting NCT03972527 - Photobiomodulation to Demonstrate Safety and Reduce the Incidence of Oral Mucositis in Adult Head & Neck Cancer Patients N/A
Recruiting NCT06354712 - Efficacy of N-acetylcysteine in Preventing Radiotherapy-Induced Oral Mucositis in Head and Neck Cancer Patients. Phase 2